Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of phenylacetamides. It features a substituted acetamide core with chloro-, fluoro-, and difluorophenylethyl functional groups. The molecule is catalogued as an experimental compound in drug databases and has not been approved for any clinical use or indication. Its mechanism of action, biological targets, pharmacological activity, and therapeutic potential have not been described in publicly available sources. There are no known clinical trials or regulatory approvals associated with this compound[1][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide.